首页> 外文期刊>Medicine. >Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study
【24h】

Association Between Catalase Gene Polymorphisms and Risk of Chronic Hepatitis B, Hepatitis B Virus-Related Liver Cirrhosis and Hepatocellular Carcinoma in Guangxi Population: A Case–Control Study

机译:过氧化氢酶基因多态性与广西人群慢性乙型肝炎,乙型肝炎病毒相关肝硬化和肝细胞癌风险的关系:病例对照研究

获取原文
           

摘要

Reactive oxygen species (ROS) play critical roles in hepatocarcinogenesis. The catalase (CAT) enzyme is involved in the repair of ROS. Therefore, we investigate the association between CAT gene polymorphisms and the risk of hepatocellular carcinoma (HCC). A total of 715 subjects were divided into 4 groups: 111 chronic hepatitis B (CHB) patients, 90 hepatitis B virus (HBV)-related liver cirrhosis (LC) patients, 266 HBV-HCC patients, and 248 healthy controls. The polymerase chain reaction-restriction fragment length polymorphism strategy was used to detect CAT gene rs1001179, rs769217, and rs7943316 polymorphisms. Binary logistic regression analyses adjusting for sex, age, ethnicity, smoking and alcohol consumption, and body mass index suggested that subjects carrying the rs769217 T allele were at marginally increased risk of CHB, LC, and HCC, with adjusted odds ratios (ORs) of 1.51 (95% confidence interval [CI] = 1.04–2.20, P = 0.029), 1.48 (95% CI = 1.03–2.14, P = 0.035), and 1.51 (95% CI = 1.14–1.98, P = 0.004), respectively. Similarly, those individuals carrying the rs769217 TT genotype had a moderately increased risk of CHB, LC, and HCC, with adjusted ORs of 2.11 (95% CI = 1.05–4.22, P = 0.035), 2.00 (95% CI, 1.01–3.95, P = 0.047), and 1.93 (95% CI = 1.14–3.28, P = 0.015), respectively. Moreover, subjects carrying the rs769217 CT genotype and at least 1 copy of the T allele (dominant model) were 1.78 times and 1.83 times more likely to develop HCC, respectively (OR = 1.78, 95% CI = 1.16–2.73, P = 0.009 and OR = 1.83, 95% CI = 1.23–2.71, P = 0.003). This association between CAT rs769217 T alleles and HCC risk is significantly strengthened among men, nonsmokers, nondrinkers, and among individuals <50 years of age. Furthermore, we found 1 high-risk haplotype GTA for CHB (OR = 1.45, 95% CI = 1.05–2.01) and 1 protective haplotype GCA for HCC risk (OR = 0.67, 95% CI = 0.52–0.87). We did not found any significant difference in CAT rs1001179 and rs7943316 polymorphisms between controls and cases. Our findings suggest that the CAT rs769217 T allele is associated with increased risk of CHB, HBV-LC, and HBV-HCC in Guangxi population.
机译:活性氧(ROS)在肝癌发生中起关键作用。过氧化氢酶(CAT)酶参与ROS的修复。因此,我们调查CAT基因多态性与肝细胞癌(HCC)风险之间的关联。共有715位受试者分为4组:111位慢性乙型肝炎(CHB)患者,90位与乙型肝炎病毒(HBV)相关的肝硬化(LC)患者,266位HBV-HCC患者和248位健康对照。使用聚合酶链反应-限制性片段长度多态性策略检测CAT基因rs1001179,rs769217和rs7943316多态性。对性别,年龄,种族,吸烟和饮酒量及体重指数进行调整的二元logistic回归分析表明,携带rs769217 T等位基因的受试者患CHB,LC和HCC的风险略有增加,且校正后的优势比(OR)为1.51(95%置信区间[CI] = 1.04–2.20,P = 0.029),1.48(95%CI = 1.03–2.14,P = 0.035)和1.51(95%CI = 1.14–1.98,P = 0.004),分别。同样,携带rs769217 TT基因型的个体罹患CHB,LC和HCC的风险适度增加,调整后的OR为2.11(95%CI = 1.05-4.22,P = 0.035),2.00(95%CI,1.01-3.95) ,P = 0.047)和1.93(95%CI = 1.14–3.28,P = 0.015)。此外,携带rs769217 CT基因型和至少1个T等位基因(优势模型)的受试者发生肝癌的可能性分别为1.78倍和1.83倍(OR = 1.78,95%CI = 1.16–2.73,P = 0.009并且OR = 1.83,95%CI = 1.23–2.71,P = 0.003)。 CAT rs769217 T等位基因与HCC风险之间的这种关联在男性,非吸烟者,非饮酒者以及<50岁的个体中显着增强。此外,我们发现CHB有1个高风险单倍型GTA(OR = 1.45,95%CI = 1.05-2.01)和HCC危险有1个保护性单倍型GCA(OR = 0.67,95%CI = 0.52-0.87)。我们没有发现对照和病例之间的CAT rs1001179和rs7943316多态性有任何显着差异。我们的发现表明,广西人群中CAT rs769217 T等位基因与CHB,HBV-LC和HBV-HCC的风险增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号